Literature DB >> 19944332

Torsades de Pointes with QT prolongation related to donepezil use.

Tomofumi Takaya1, Masashi Okamoto, Keiko Yodoi, Katsuya Hata, Yoichi Kijima, Hideto Nakajima, Yuji Nishikawa, Tomoyuki Kita, Mitsuaki Ito, Toshihiko Seo, Seinosuke Kawashima.   

Abstract

An 83-year-old female, who had a history of anterior myocardial infarction, was treated for Alzheimer's disease with donepezil. She suffered from repeated diarrhea and vomiting, and experienced syncope. She was admitted to our hospital and was diagnosed with acute colitis and syncope. On admission, her heart rate was 54 beats/min with regular rhythm. Laboratory data showed a low plasma potassium level. Electrocardiogram (ECG) showed poor R progression, ST elevation, negative T in precordial leads, and marked QT prolongation. Transthoracic echocardiogram showed the enlargement of the left atrium and aneurysmal area at the apex. Torsades de Pointes (TdP) with syncope and convulsion were confirmed on ECG monitoring twice after admission. We treated her with potassium chloride and started magnesium sulfate and lidocaine, and then added isoprenaline injection. After these treatments, her heart rate increased and we did not detect TdP again. With the aging population in Japan, prescriptions for donepezil are increasing. We have to be vigilant for syncope in patients taking donepezil, which is possibly related to QT prolongation and TdP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19944332     DOI: 10.1016/j.jjcc.2009.03.011

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  18 in total

Review 1.  Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.

Authors:  Galia Jackobson; Narin Nard Carmel; Dor Lotan; Anjelika Kremer; Dan Justo
Journal:  Z Gerontol Geriatr       Date:  2016-11-22       Impact factor: 1.281

2.  Use of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: a population-based, nested case-control study.

Authors:  Janine R Hutson; Hadas D Fischer; Xuesong Wang; Andrea Gruneir; Nick Daneman; Sudeep S Gill; Paula A Rochon; Geoffrey M Anderson
Journal:  Drugs Aging       Date:  2012-03-01       Impact factor: 3.923

3.  A case of donepezil-related torsades de pointes.

Authors:  Jamie Kitt; Robert Irons; Mohamed Al-Obaidi; Constantinos Missouris
Journal:  BMJ Case Rep       Date:  2015-10-05

4.  Lesson of the month 1: Prolonged QT syndrome due to donepezil: a reversible cause of falls?

Authors:  Emily G Jackson; Sarah Stowe
Journal:  Clin Med (Lond)       Date:  2019-01       Impact factor: 2.659

Review 5.  Alzheimer's disease therapy based on acetylcholinesterase inhibitor/blocker effects on voltage-gated potassium channels.

Authors:  Xian-Tao Li
Journal:  Metab Brain Dis       Date:  2022-01-31       Impact factor: 3.584

Review 6.  Cardiovascular effects of drugs used to treat Alzheimer's disease.

Authors:  Laurence Guy Howes
Journal:  Drug Saf       Date:  2014-06       Impact factor: 5.606

7.  Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events.

Authors:  Sayaka Sasaoka; Toshinobu Matsui; Yuuki Hane; Junko Abe; Natsumi Ueda; Yumi Motooka; Haruna Hatahira; Akiho Fukuda; Misa Naganuma; Shiori Hasegawa; Yasutomi Kinosada; Mitsuhiro Nakamura
Journal:  PLoS One       Date:  2016-10-10       Impact factor: 3.240

8.  Inhibitory effects of cholinesterase inhibitor donepezil on the Kv1.5 potassium channel.

Authors:  Kai Li; Neng Cheng; Xian-Tao Li
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

9.  Electrocardiogram Changes of Donepezil Administration in Elderly Patients with Ischemic Heart Disease.

Authors:  Deguo Wang; Yong Wu; Ancai Wang; Yueyun Chen; Ting Zhang; Nengwei Hu
Journal:  Cardiol Res Pract       Date:  2018-04-23       Impact factor: 1.866

Review 10.  Prophylactic lidocaine for myocardial infarction.

Authors:  Arturo J Martí-Carvajal; Daniel Simancas-Racines; Vidhu Anand; Shrikant Bangdiwala
Journal:  Cochrane Database Syst Rev       Date:  2015-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.